Development and characterization of a stable eGFP enterovirus 71 for antiviral screening

Baodi Shang, Chenglin Deng, Hanqing Ye, Wenbo Xu, Zhiming Yuan, Pei-Yong Shi, Bo Zhang

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Enterovirus 71 (EV71) is one of the major causative agents for hand, foot, and mouth disease. There is currently no clinically approved vaccine or antiviral treatment for EV71 infection. To facilitate antiviral drug discovery, we developed an infectious cDNA clone of an epidemic strain of EV71 and a stable eGFP reporter EV71. The reporter virus was generated by engineering the eGFP gene between the 5' untranslated region and VP4 gene of the EV71 genome. Vero cells transfected with the cDNA clone-derived RNA generated high titers (>106PFU/ml) of the eGFP reporter virus. The reporter virus was infectious to Vero cells, producing robust eGFP fluorescence signals. Compared with the wild type virus, the reporter virus replicated slower in cell culture. To examine the stability of the reporter virus, we continuously passaged the virus on Vero cells for five rounds. The passaged viruses maintained the eGFP gene, demonstrating the stability of the reporter virus. Using a known EV71 inhibitor, we demonstrate that the reporter virus could be used for antiviral screening. The infectious cDNA clones of the wild type virus and the eGFP reporter viruses will be useful for antiviral research as well as for studying viral replication and pathogenesis of EV71.

Original languageEnglish (US)
Pages (from-to)198-205
Number of pages8
JournalAntiviral Research
Volume97
Issue number2
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

Enterovirus
Antiviral Agents
Viruses
Vero Cells
Complementary DNA
Clone Cells
Hand, Foot and Mouth Disease
Enterovirus Infections
Genes
5' Untranslated Regions
Drug Discovery
Vaccines
Cell Culture Techniques
Fluorescence
Genome
RNA

Keywords

  • Antiviral drug discovery
  • Enterovirus
  • High-throughput assay
  • Reporter virus

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. / Shang, Baodi; Deng, Chenglin; Ye, Hanqing; Xu, Wenbo; Yuan, Zhiming; Shi, Pei-Yong; Zhang, Bo.

In: Antiviral Research, Vol. 97, No. 2, 02.2013, p. 198-205.

Research output: Contribution to journalArticle

Shang, Baodi ; Deng, Chenglin ; Ye, Hanqing ; Xu, Wenbo ; Yuan, Zhiming ; Shi, Pei-Yong ; Zhang, Bo. / Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. In: Antiviral Research. 2013 ; Vol. 97, No. 2. pp. 198-205.
@article{c156533e7c90492ba05ca4b5014494ec,
title = "Development and characterization of a stable eGFP enterovirus 71 for antiviral screening",
abstract = "Enterovirus 71 (EV71) is one of the major causative agents for hand, foot, and mouth disease. There is currently no clinically approved vaccine or antiviral treatment for EV71 infection. To facilitate antiviral drug discovery, we developed an infectious cDNA clone of an epidemic strain of EV71 and a stable eGFP reporter EV71. The reporter virus was generated by engineering the eGFP gene between the 5' untranslated region and VP4 gene of the EV71 genome. Vero cells transfected with the cDNA clone-derived RNA generated high titers (>106PFU/ml) of the eGFP reporter virus. The reporter virus was infectious to Vero cells, producing robust eGFP fluorescence signals. Compared with the wild type virus, the reporter virus replicated slower in cell culture. To examine the stability of the reporter virus, we continuously passaged the virus on Vero cells for five rounds. The passaged viruses maintained the eGFP gene, demonstrating the stability of the reporter virus. Using a known EV71 inhibitor, we demonstrate that the reporter virus could be used for antiviral screening. The infectious cDNA clones of the wild type virus and the eGFP reporter viruses will be useful for antiviral research as well as for studying viral replication and pathogenesis of EV71.",
keywords = "Antiviral drug discovery, Enterovirus, High-throughput assay, Reporter virus",
author = "Baodi Shang and Chenglin Deng and Hanqing Ye and Wenbo Xu and Zhiming Yuan and Pei-Yong Shi and Bo Zhang",
year = "2013",
month = "2",
doi = "10.1016/j.antiviral.2012.12.010",
language = "English (US)",
volume = "97",
pages = "198--205",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Development and characterization of a stable eGFP enterovirus 71 for antiviral screening

AU - Shang, Baodi

AU - Deng, Chenglin

AU - Ye, Hanqing

AU - Xu, Wenbo

AU - Yuan, Zhiming

AU - Shi, Pei-Yong

AU - Zhang, Bo

PY - 2013/2

Y1 - 2013/2

N2 - Enterovirus 71 (EV71) is one of the major causative agents for hand, foot, and mouth disease. There is currently no clinically approved vaccine or antiviral treatment for EV71 infection. To facilitate antiviral drug discovery, we developed an infectious cDNA clone of an epidemic strain of EV71 and a stable eGFP reporter EV71. The reporter virus was generated by engineering the eGFP gene between the 5' untranslated region and VP4 gene of the EV71 genome. Vero cells transfected with the cDNA clone-derived RNA generated high titers (>106PFU/ml) of the eGFP reporter virus. The reporter virus was infectious to Vero cells, producing robust eGFP fluorescence signals. Compared with the wild type virus, the reporter virus replicated slower in cell culture. To examine the stability of the reporter virus, we continuously passaged the virus on Vero cells for five rounds. The passaged viruses maintained the eGFP gene, demonstrating the stability of the reporter virus. Using a known EV71 inhibitor, we demonstrate that the reporter virus could be used for antiviral screening. The infectious cDNA clones of the wild type virus and the eGFP reporter viruses will be useful for antiviral research as well as for studying viral replication and pathogenesis of EV71.

AB - Enterovirus 71 (EV71) is one of the major causative agents for hand, foot, and mouth disease. There is currently no clinically approved vaccine or antiviral treatment for EV71 infection. To facilitate antiviral drug discovery, we developed an infectious cDNA clone of an epidemic strain of EV71 and a stable eGFP reporter EV71. The reporter virus was generated by engineering the eGFP gene between the 5' untranslated region and VP4 gene of the EV71 genome. Vero cells transfected with the cDNA clone-derived RNA generated high titers (>106PFU/ml) of the eGFP reporter virus. The reporter virus was infectious to Vero cells, producing robust eGFP fluorescence signals. Compared with the wild type virus, the reporter virus replicated slower in cell culture. To examine the stability of the reporter virus, we continuously passaged the virus on Vero cells for five rounds. The passaged viruses maintained the eGFP gene, demonstrating the stability of the reporter virus. Using a known EV71 inhibitor, we demonstrate that the reporter virus could be used for antiviral screening. The infectious cDNA clones of the wild type virus and the eGFP reporter viruses will be useful for antiviral research as well as for studying viral replication and pathogenesis of EV71.

KW - Antiviral drug discovery

KW - Enterovirus

KW - High-throughput assay

KW - Reporter virus

UR - http://www.scopus.com/inward/record.url?scp=84872132019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872132019&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2012.12.010

DO - 10.1016/j.antiviral.2012.12.010

M3 - Article

C2 - 23267829

AN - SCOPUS:84872132019

VL - 97

SP - 198

EP - 205

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 2

ER -